In a study using next-generation sequencing to identify plasma miRNA markers in patients with GDM in early pregnancy, 17 miRNAs associated with GDM development were identified, which may be involved in the regulation of lipid metabolism and insulin sensitivity (IS). This evidence concerns the gene INS and gestational diabetes.